IM Cannabis
Glil Yam
About IM Cannabis
IM Cannabis produces and distributes medical cannabis. Its products include products for patients and offer research and development of new genetic strains. Oren Shuster and Rafael Gabay founded IM cannabis in Glil Yam, Tel Aviv in 2010.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $69.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: cse:IMCC
- Website: imcannabis.com
- Phone: +972 77-444-2333
Industries & Categories
Cannabis, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/im-cannabis-81606 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.